Glucotrack, INC DEF 14A proxy statements

Glucotrack, Inc. is holding a special meeting on September 11, 2026, to seek shareholder approval for significant stock issuances related to financing agreements, which may result in substantial dilution.

Glucotrack, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for August 18, 2026, to address key proposals including director elections, executive compensation, auditor ratification, a reverse stock split, and a warrant inducement.

Glucotrack, Inc. calls a Special Meeting to approve significant stock issuances for capital raises and ratify its independent auditor.

Glucotrack, Inc.'s special meeting of stockholders was permanently adjourned and cancelled after failing to achieve a quorum on two separate occasions.

Glucotrack, Inc. reconvenes its Special Meeting of Shareholders on November 7, 2025, to vote on a $20 million Equity Purchase Agreement with Sixth Borough Capital Fund LP.

Glucotrack, Inc. announced the adjournment of its Special Meeting of Stockholders from October 31, 2025, to November 7, 2025, with no changes to the record date or proposals.

Glucotrack, Inc. reminds shareholders to vote on an Equity Purchase Agreement with Sixth Borough Capital Fund at a Special Meeting on October 31, 2025.

Glucotrack, Inc. issued a reminder to stockholders to cast their votes for the upcoming Special Meeting scheduled for October 31, 2025.

Glucotrack, Inc. calls a Special Meeting to approve the issuance of over 20% of its common stock to Sixth Borough Capital Fund, LP for a $20 million equity financing facility.

Glucotrack is asking stockholders to approve a reverse stock split, elect directors, ratify the appointment of its accounting firm, and amend its equity incentive plan at the upcoming annual meeting.

Glucotrack is holding a special meeting to seek stockholder approval for a share issuance related to warrants, a reverse stock split, and an increase in authorized shares.

Glucotrack is holding a special meeting on September 24, 2024, to seek stockholder approval for the issuance of shares related to a recent financing agreement.

GlucoTrack is asking stockholders to approve a new equity incentive plan and a reverse stock split to maintain its Nasdaq listing at its upcoming annual meeting.